IONS

NASDAQ 已收盘

Ionis Pharmaceuticals

27.22 USD
▼-0.17-0.62%
盘后 27.38 +0.57%
2026-11-19
市值
$4.57B
市盈率
—
EPS
-3.32
股息率
—
52 周区间
26.55 – 86.74
成交量
3.06M
Beta
0.40
目标价
67.83
52W 低 26.5552W 高 86.74
价格走势

公司简介

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also ...

关联新闻